MedPath

Vein External Support Trial

Not Applicable
Completed
Conditions
Coronary Heart Disease
Interventions
Device: Fluent (VGS Fluent external support device)
Registration Number
NCT01415245
Lead Sponsor
Vascular Graft Solutions Ltd.
Brief Summary

Prospective, multi-center, randomized, controlled pilot study to demonstrate the safety and effectiveness of the VGS Fluent external support device, supporting saphenous vein grafts in patients with coronary heart disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Patient scheduled for on-pump CABG on clinical grounds
  2. Vein grafts indicated for right and circumflex coronary arteries and LIMA indicated for the LAD on clinical grounds
  3. Native circumflex and right coronary arteries have at least one stenosis in each vessel> 75%

Primary

Exclusion Criteria
  1. Concomitant non-CABG cardiac procedure
  2. Prior peripheral vascular or cardiac surgery
  3. Emergency CABG surgery (cardiogenic shock, inotrophic pressure support, IABP)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TreatmentFluent (VGS Fluent external support device)Device applied to saphenous vein graft
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Harefield Hospital

🇬🇧

Middlesex, United Kingdom

The John Radcliffe Hospital

🇬🇧

Oxford, United Kingdom

Royal Brompton Hospital

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath